Elevate Campuses Limited (NSE:ELEVATE)
India · Delayed Price · Currency is INR 330.85
-2.30 (-0.69%)
Oct 6, 2026, 9:30 AM IST
Elevate Campuses Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Other Revenue | 5,686 | 3,698 | 3,470 | 2,925 | 1,094 |
| 5,686 | 3,698 | 3,470 | 2,925 | 1,094 | |
Revenue Growth (YoY | 53.76% | 6.57% | 18.63% | 167.44% | - |
Property Expenses | 181.57 | 131.89 | 173.63 | 129.94 | 51.15 |
Selling, General & Administrative | 17.28 | 1.95 | 9.99 | 9.23 | 28.72 |
Depreciation & Amortization | 1,021 | 512.35 | 487.62 | 438.14 | 423.35 |
Other Operating Expenses | 1,406 | 1,137 | 1,141 | 835.31 | 412.08 |
Total Operating Expenses | 2,626 | 1,783 | 1,812 | 1,413 | 915.3 |
Operating Income | 3,060 | 1,915 | 1,658 | 1,512 | 178.4 |
Interest Expense | -2,522 | -1,217 | -1,078 | -1,036 | -1,075 |
Interest & Investment Income | 114.89 | 139.84 | 142.01 | 81.28 | 63.52 |
Currency Exchange Gain (Loss) | 1.3 | - | - | - | - |
Other Non-Operating Income | 189.47 | -17.09 | -0.67 | 2.71 | 2.1 |
EBT Excluding Unusual Items | 843.44 | 820.76 | 721.81 | 560.32 | -831.06 |
Merger & Restructuring Charges | -32.02 | - | -13.36 | - | - |
Gain (Loss) on Sale of Investments | 172.31 | 77.22 | - | - | - |
Gain (Loss) on Sale of Assets | 0.82 | - | 0.18 | - | - |
Total Insurance Settlements | - | 5.01 | - | - | - |
Other Unusual Items | 1,053 | -106.73 | -87.3 | -168.32 | -6.57 |
Pretax Income | 2,038 | 796.26 | 621.33 | 392 | -837.63 |
Income Tax Expense | 300.03 | 298.88 | 224.44 | 101.97 | -167.75 |
Net Income | 1,738 | 497.38 | 396.89 | 290.03 | -669.88 |
Net Income to Common | 1,738 | 497.38 | 396.89 | 290.03 | -669.88 |
Net Income Growth | 249.35% | 25.32% | 36.84% | - | - |
Basic Shares Outstanding | 88 | 88 | 22 | 22 | 22 |
Diluted Shares Outstanding | 98 | 88 | 22 | 22 | 22 |
Shares Change | 10.34% | 297.93% | - | 1.32% | - |
EPS (Basic) | 19.65 | 5.63 | 17.94 | 13.11 | -30.55 |
EPS (Diluted) | 17.81 | 5.63 | 17.86 | 13.05 | -30.55 |
EPS Growth | 216.61% | -68.50% | 36.86% | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Margin | 53.81% | 51.79% | 47.79% | 51.70% | 16.31% |
Profit Margin | 30.56% | 13.45% | 11.44% | 9.92% | -61.25% |
EBITDA | 4,063 | 2,412 | 2,128 | 1,929 | 587.42 |
EBITDA Margin | 71.46% | 65.22% | 61.31% | 65.96% | 53.71% |
D&A For Ebitda | 1,003 | 496.65 | 469.37 | 416.94 | 409.02 |
EBIT | 3,060 | 1,915 | 1,658 | 1,512 | 178.4 |
EBIT Margin | 53.81% | 51.79% | 47.79% | 51.70% | 16.31% |
Effective Tax Rate | 14.72% | 37.54% | 36.12% | 26.01% | - |
Revenue as Reported | 6,034 | 3,941 | 3,626 | 3,009 | 1,160 |